TEGNA Inc. (TGNA) continued its upward trend with the stock climbing 0.75% or $0.18 to close the day at $24.33 on active trading volume of 1.8M shares, compared to its three month average trading volume of 1.78M. The McLean Virginia 22107 based company has been outperforming the broadcasting – tv group over the past 52 weeks, with the stock gaining 2.9%, compared to the industry which has advanced 25.4% over the same period. With RSI of 79.03, the stock should still continue to rise and get closer to its one year target estimate of $24.57, making it a hold for now.
TEGNA Inc. engages in media and digital businesses in the United States. The company operates in two segments, Media and Digital. It operates 46 television stations that produce local programming, such as news, sports, and entertainment. The company also operates Cars.com, an online destination for automotive consumers that offers information about car shopping, selling, and servicing; CareerBuilder, which provides human capital solutions, such as employment data and labor market analysis software, talent management software, and other advertising and recruitment solutions; G/O Digital that provides digital marketing services for local businesses; and Cofactor, a digital marketing company that enable brands to deliver content. In addition, it offers advertising and marketing solutions. The company serves approximately 90 million customers through its broadcast and digital media platforms. The company was formerly known as Gannett Co., Inc. and changed its name to TEGNA Inc. in June 2015. TEGNA Inc. was founded in 1906 and is headquartered in McLean, Virginia.
American Outdoor Brands Corporation (AOBC) retreated with the stock falling -1.98% or $-0.38 to close at $18.84 on light trading volume of 1.8M compared its three months average trading volume of 1.9M. The Springfield Massachusetts 01104 based company has been trending down for the last 52 weeks, with the shares price now -18.76% down for the period and down by -10.63% so far this year. With price target of $25.75 and a 0.16% rebound from 52-week low, American Outdoor Brands Corporation has plenty of upside potential, making it a hold with a view buy.
American Outdoor Brands Corporation manufactures and sells firearm products and accessories. The company operates in two segments, Firearms and Accessories. It offers handguns, long guns, hunting rifles, black powder firearms, handcuffs and restraints, and firearm-related products. The company also provides accessories, such as reloading, gunsmithing tools, gun cleaning supplies, tree saws, shooting and field rests, gun vises, hearing protection, ammo tumblers, and vault accessories. It sells its products under the Smith & Wesson, M&P, Thompson/Center Arms, Caldwell Shooting Supplies, Wheeler Engineering, Tipton Gun Cleaning Supplies, Frankford Arsenal Reloading Tools, Lockdown Vault Accessories, Hooyman Premium Tree Saws, BOG-POD, and Golden Rod Moisture Control brands. In addition, the company sells parts of other brands; operates a private law enforcement training facility; provides metal processing and finishing services comprising tooling, forging, heat treating, finishing, plating, and plastic injection molding, as well as engineering support services to third-party customers; and licenses trademarks to third parties. It serves gun enthusiasts; collectors; hunters; sportsmen; competitive shooters; individuals desiring home and personal protection; law enforcement and security agencies and officers; and military agencies. The company markets products through dealers, retailers, in-store retail channels, and range operations utilizing consumer-focused product marketing and promotional campaigns; social and electronic media; and in-store retail merchandising systems and strategies. It also operates Websites; and online retail stores that sells hunting and shooting accessories, branded products, apparel, and related shooting supplies. The company was formerly known as Smith & Wesson Holding Corporation and changed its name to American Outdoor Brands Corporation in January 2017. The company was founded in 1852 and is based in Springfield, Massachusetts.
Antares Pharma, Inc. (ATRS) continued its upward trend with the stock climbing 5.81% or $0.14 to close the day at $2.55 on lower than average trading volume of 1.8M shares, compared to its three month average trading volume of 903.48K. The Ewing New Jersey 08628 based company has been outperforming the medical instruments & supplies companies by 32.6965% for last three months and its recent gains have pushed the stock slightly up 9.44% YTD, versus the medical instruments & supplies industry which is up 8.7% for the same period. The RSI of 72.42 indicates the stock is overbought at the current levels, sell for now.
Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; ZOMA-Jet and Twin-Jector, a needle-free auto injector to deliver human growth hormone treatment to children without the use of a needle; and VIBEX disposable pressure-assisted auto injectors. It also offers Elestrin gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; and Gelnique, an oxybutynin gel product for the treatment of overactive bladder. In addition, the company is developing VIBEX auto injectors for treating anaphylaxis; disposable pen injectors for diabetes; VIBEX QuickShot (QS) auto injectors for reducing risk of preterm birth; VIBEX QS Testosterone for testosterone replacement therapy for men who have testosterone deficiency; and Vibex QS M for the treatment of CNS indication. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals Inc. and Ferring B.V.; JCR Pharmaceuticals Co., Ltd.; Teva Pharmaceutical Industries, Ltd.; Actavis plc; Meda Pharmaceuticals, Inc.; and AMAG Pharmaceuticals, Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.